Chondroitin Sulphate Efficay/Safety in Patients With Knee Osteoarthritis and Psoriasis [clinicaltrials:NCT00669123]
Chondroitin Sulphate Efficay/Safety in Patients With Knee Osteoarthritis and Psoriasis [clinicaltrials:NCT00669123]
Bio2RDF identifier
NCT00669123
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00669123
identifiers.org URI
actual enrollment [clinicaltrials_vocabulary:actual-enrollment]
arm group [clinicaltrials_vocabulary:arm-group]
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
The purpouse of this st ...... thritis and plaque psoriasis.
brief title [clinicaltrials_vocabulary:brief-title]
Chondroitin Sulphate Efficay/Safety in Patients With Knee Osteoarthritis and Psoriasis
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
condition [clinicaltrials_vocabulary:condition]
condition browse [clinicaltrials_vocabulary:condition-browse]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
country [clinicaltrials_vocabulary:country]
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
2008-04-24T00:00:00Z
has expanded access [clinicaltrials_vocabulary:has-expanded-access]
intervention [clinicaltrials_vocabulary:intervention]
is fda regulated [clinicaltrials_vocabulary:is-fda-regulated]
keyword [clinicaltrials_vocabulary:keyword]
Chondroitin sulphate
Knee osteoarthritis
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2008-04-28T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
location [clinicaltrials_vocabulary:location]
nct id [clinicaltrials_vocabulary:nct-id]
NCT00669123
number of arms [clinicaltrials_vocabulary:number-of-arms]
official title [clinicaltrials_vocabulary:official-title]
Fase IV Clinical Trial to Eval ...... e Osteoarthritis and Psoriasis
org study id [clinicaltrials_vocabulary:org-study-id]
CS/IV/PSO/ART
overall official [clinicaltrials_vocabulary:overall-official]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
phase [clinicaltrials_vocabulary:phase]
responsible party [clinicaltrials_vocabulary:responsible-party]
source [clinicaltrials_vocabulary:source]
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2008-04-01T00:00:00Z
identifier
clinicaltrials:NCT00669123
title
Chondroitin Sulphate Efficay/Safety in Patients With Knee Osteoarthritis and Psoriasis
@en
type
label
Chondroitin Sulphate Efficay/S ...... s [clinicaltrials:NCT00669123]
@en